CVE-2024-23280

MEDIUM
Published Mar 8, 2024 Modified Apr 2, 2026 CWE-74

Description

An injection issue was addressed with improved validation. This issue is fixed in Safari 17.4, iOS 17.4 and iPadOS 17.4, macOS Sonoma 14.4, tvOS 17.4, watchOS 10.4. A maliciously crafted webpage may be able to fingerprint the user.

Is your site exposed to CVE-2024-23280?

Run a free security scan — no signup, results in seconds.

CVSS v3.1 Score

6.5
MEDIUM
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

Weakness Type (CWE)

CWE-74 CWE-74

Affected Products

Vendor Product
apple safari
apple ipad_os
apple iphone_os
apple macos
apple tvos
apple watchos
fedoraproject fedora
fedoraproject fedora
fedoraproject fedora
webkitgtk webkitgtk
wpewebkit wpe_webkit

References

Frequently Asked Questions

What is CVE-2024-23280? +
An injection issue was addressed with improved validation. This issue is fixed in Safari 17.4, iOS 17.4 and iPadOS 17.4, macOS Sonoma 14.4, tvOS 17.4, watchOS 10.4. A maliciously crafted webpage may be able to fingerprint the user. It has a CVSS v3.1 base score of 6.5 (MEDIUM).
How severe is CVE-2024-23280? +
CVE-2024-23280 has a CVSS v3.1 score of 6.5 out of 10, rated MEDIUM. This is a medium-severity vulnerability that should be remediated as part of regular maintenance.
What products are affected by CVE-2024-23280? +
CVE-2024-23280 affects products from apple, fedoraproject, webkitgtk, wpewebkit, specifically: fedora, ipad_os, iphone_os, macos, safari, tvos, watchos, webkitgtk, wpe_webkit. Check the affected products table above for specific version ranges.
How do I check if I'm vulnerable to CVE-2024-23280? +
You can use Secably's free Website Scanner to check your website for known vulnerabilities. For infrastructure scanning, use the Port Scanner to identify exposed services that may be affected. Check the vendor advisories linked above for specific patch and version information.

Related Vulnerabilities

Don't wait for an exploit

Scan your website for vulnerabilities like CVE-2024-23280 — free, no signup required.